Using a well-annotated cohort of patients with treatment information and long term clinical follow-up, we examined the immunohistochemical expression of PD-L1 in tumor cells and the microenvironment, and correlated these data with additional histologic parameters and clinical outcome data. The gene discussed is CD274; the disease is neoplasm.